Latest News by Industry
NEUROCRINE BIOSCIENCES INC [NBIX] has reported fiscal Q1 profit of $76.60 million.
On a per-share basis, the DE based company said its diluted earnings are $0.79.
The Biological Products, Except Diagnostic Substances firm posted revenue of $420.40 million in this period.
Also Read: